TGR-1202 + ibrutinib in patients with relapsed or refractory CLL
New chemotherapy-free approaches for the treatment of lymphoid malignancies
At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...
Anthony Mato | ASH 2018 | CLL treatment updates and prognostic testing
Anthony Mato from the Memorial Sloan Kettering Cancer Center discusses CLL treatment updates and prognostic testing.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month